Byrd JC - Search Results

1

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.

Zhong Y, El-Gamal D, Dubovsky JA, Beckwith KA, Harrington BK, Williams KE, Goettl VM, Jha S, Mo X, Jones JA, Flynn JM, Maddocks KJ, Andritsos LA, McCauley D, Shacham S, Kauffman M, Byrd JC, Lapalombella R. Zhong Y, et al. Among authors: byrd jc. Leukemia. 2014 May;28(5):1158-63. doi: 10.1038/leu.2014.9. Epub 2014 Jan 13. Leukemia. 2014. PMID: 24413321 Free PMC article. No abstract available.

2

Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived.

Waselenko JK, Flynn JM, Byrd JC. Waselenko JK, et al. Among authors: byrd jc. Semin Oncol. 1999 Feb;26(1):48-61. Semin Oncol. 1999. PMID: 10073561 Review.

3

Campath-1H monoclonal antibody therapy.

Flynn JM, Byrd JC. Flynn JM, et al. Among authors: byrd jc. Curr Opin Oncol. 2000 Nov;12(6):574-81. doi: 10.1097/00001622-200011000-00010. Curr Opin Oncol. 2000. PMID: 11085457 Review.

4

Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.

Waselenko JK, Grever MR, Shinn CA, Flinn IW, Byrd JC. Waselenko JK, et al. Among authors: byrd jc. Leuk Res. 2001 Jun;25(6):435-40. doi: 10.1016/s0145-2126(00)00106-5. Leuk Res. 2001. PMID: 11337014

5

Novel presentation of acute myelogenous leukemia as symptomatic galactorrhea.

Ales N, Flynn J, Byrd JC. Ales N, et al. Among authors: byrd jc. Ann Intern Med. 2001 Aug 21;135(4):303-4. doi: 10.7326/0003-4819-135-4-200108210-00025. Ann Intern Med. 2001. PMID: 11511155 No abstract available.

6

Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.

Waselenko JK, Shinn CA, Willis CR, Flinn IW, Grever MR, Byrd JC. Waselenko JK, et al. Among authors: byrd jc. Leuk Lymphoma. 2001 Sep-Oct;42(5):1049-53. doi: 10.3109/10428190109097725. Leuk Lymphoma. 2001. PMID: 11697622

7

A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.

Byrd JC, Peterson B, Piro L, Saven A, Vardiman JW, Larson RA, Schiffer C. Byrd JC, et al. Leukemia. 2003 Feb;17(2):323-7. doi: 10.1038/sj.leu.2402752. Leukemia. 2003. PMID: 12592330 Clinical Trial.

8

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells.

Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Klisovic MI, et al. Among authors: byrd jc. Leukemia. 2003 Feb;17(2):350-8. doi: 10.1038/sj.leu.2402776. Leukemia. 2003. PMID: 12592335

9

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells.

Lucas DM, Davis ME, Parthun MR, Mone AP, Kitada S, Cunningham KD, Flax EL, Wickham J, Reed JC, Byrd JC, Grever MR. Lucas DM, et al. Among authors: byrd jc. Leukemia. 2004 Jul;18(7):1207-14. doi: 10.1038/sj.leu.2403388. Leukemia. 2004. PMID: 15116122

10

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia.

Lin TS, Flinn IW, Lucas MS, Porcu P, Sickler J, Moran ME, Lucas DM, Heerema NA, Grever MR, Byrd JC. Lin TS, et al. Among authors: byrd jc. Leukemia. 2005 Jul;19(7):1207-10. doi: 10.1038/sj.leu.2403782. Leukemia. 2005. PMID: 15858611 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters